Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Classic Follicular Lymphoma × Hyaluronoglucosaminidase × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Locally Recurrent Skin Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Classic Follicular Lymphoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 1 Rituximab 1 Magnetic Resonance Spectroscopy 1 Hyaluronoglucosaminidase 1 CT-P10 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06337318 2026-03-18

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

National Cancer Institute (NCI)

Phase 3 Recruiting

Classic Follicular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡